Literature DB >> 17271439

Lethal and inhibitory effects of steep pulsed electric field on tumor-bearing BALB/c mice.

Yan Mi1, Caixin Sun, Chenguo Yao, Lan Xiong, Ruijin Liao, Ya Hu, Lina Hu.   

Abstract

Exposing cancer cell to steep pulsed electric field (SPEF) with appropriate dosage, the cell may die due to irreversible electrical breakdown (IREB). 48 BALB/c mice inoculated with U/sub 14/ cervical cancer cell were treated with SPEF to study the lethal and inhibitory effects of SPEF on them. They were randomly divided into test group (26) and control group (22), and then four experiments were carried out. Histological observation and ultrastructural observation showed that SPEF destroyed the integrality of tumor cell irreversibly with pyknosis, karyoclasis and karyolysis. Tumor volume measurement indicated that SPEF significantly slowed down the growth speed of tumor. In the experiment of survival time investigation, the average survival time of control group and test group was 33.03 days and no less than 52.05 days respectively, which confirmed that SPEF prolonged the survival time of tumor-bearing mice obviously. With further experimental study and mechanism analysis, this technique is quite possible to be an effective physiotherapy for tumor treatment.

Entities:  

Year:  2004        PMID: 17271439     DOI: 10.1109/IEMBS.2004.1404383

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  2 in total

1.  Synergistic effects of nanosecond pulsed electric fields combined with low concentration of gemcitabine on human oral squamous cell carcinoma in vitro.

Authors:  Jing Wang; Jinsong Guo; Shan Wu; Hongqing Feng; Shujun Sun; Jie Pan; Jue Zhang; Stephen J Beebe
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

2.  The effect of high frequency steep pulsed electric fields on in vitro and in vivo antitumor efficiency of ovarian cancer cell line skov3 and potential use in electrochemotherapy.

Authors:  Xiao-Jun Yang; Jun Li; Cai-Xin Sun; Fei-Yun Zheng; Li-Na Hu
Journal:  J Exp Clin Cancer Res       Date:  2009-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.